
BioNTech Eyes Morocco for Potential mRNA Vaccine Factory in Africa Expansion
BioNTech, a German biotechnology company specializing in the development and manufacture of active immunotherapies in the treatment of serious diseases, is betting on Africa to boost its production. In this sense, it plans to open a factory in one of the following five countries: Morocco , Egypt, South Africa, Tunisia or Senegal.










